LBO — INTERMOUNTAIN MEDICAL CENTER
IRR: 18.0% | MOIC: 2.28x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.0%
IRR
2.28x
MOIC
$1.1B
Entry EV
$1.8B
Exit EV
$586.3M
Equity Invested
Sources & Uses
S&UTotal · $1.1B| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $442.5M | 38.8% | |
| Sub Debt | $110.6M | 9.7% | |
| Equity | $586.3M | 51.5% | |
| Enterprise Value | $1.1B | 97.1% | |
| Transaction Fees | $33.2M | 2.9% | |
| Total Uses | $1.1B | 100.0% |
Interpretation
INTAt 2.28x MOIC and 18.0% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $172.3M |
| Exit Ev | $1.8B |
| Net Debt At Exit | $470.2M |
| Equity At Exit | $1.3B |
| Equity Invested | $586.3M |
| Total Value Created | $752.6M |
| Value From Growth | $647.7M |
| Value From Multiple | $55.3M |
| Value From Deleveraging | $82.9M |